• About
    • Company Overview
    • History
    • Management
    • Board of Directors
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Studies Now Enrolling
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • CI-8993
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
      • Contact the Board
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Financial Statements
    • Stock Performance
      • Interactive Chart
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact
  • About
    • Company Overview
    • History
    • Management
    • Board of Directors
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Studies Now Enrolling
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • CI-8993
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Financial Statements
    • Stock Performance
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact

Financial Information

NASDAQCRIS
$0.76
NASDAQCRIS
Open
$0.78
Change
-$0.00 (-0.03%)
Day's Range
$0.75 - $0.79
52-Week Range
$0.47 - $3.76
Volume
340.8K
Market Cap
$73.3M
Currency in USD.
Quote data delayed by at least 15 minutes.
© Curis, Inc. 2023 - All Rights Reserved
  • Terms of Use
  • Privacy Policy

This website uses cookies to improve your browsing experience and analyze site traffic. By using our site, you consent to our use of cookies, in accordance with our privacy policies. I Understand

  • About
    • Company Overview
    • History
    • Management
    • Board of Directors
  • Collaborations
    • Partner Collaborations
    • Scientific & Research Collaborations
  • Patients
    • Patients Overview
    • About Clinical Studies
    • Studies Now Enrolling
  • Pipeline
    • Pipeline Overview
    • CA-4948
    • CI-8993
    • Fimepinostat
    • CA-170
    • CA-327
    • Erivedge®
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financial Information
      • SEC Filings
      • Annual Reports
      • Quarterly Results
      • Key Ratios
      • Financial Statements
    • Stock Performance
    • Contact Us
  • Careers
    • Life at Curis
    • Open Positions
    • Benefits
  • Contact